Thomas L. Lenz

1.1k total citations
72 papers, 741 citations indexed

About

Thomas L. Lenz is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Thomas L. Lenz has authored 72 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Geriatrics and Gerontology, 16 papers in Cardiology and Cardiovascular Medicine and 10 papers in Pharmacology. Recurrent topics in Thomas L. Lenz's work include Pharmaceutical Practices and Patient Outcomes (16 papers), Pharmacology and Obesity Treatment (8 papers) and Obesity and Health Practices (7 papers). Thomas L. Lenz is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (16 papers), Pharmacology and Obesity Treatment (8 papers) and Obesity and Health Practices (7 papers). Thomas L. Lenz collaborates with scholars based in United States. Thomas L. Lenz's co-authors include Daniel E. Hilleman, Michael S. Monaghan, William Hamilton, Richard L. Wurdeman, Michele A. Faulkner, Amy Wilson, Aryan N. Mooss, Syed M. Mohiuddin, Kathleen A. Packard and Christopher J. Destache and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Sports Medicine.

In The Last Decade

Thomas L. Lenz

66 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas L. Lenz United States 16 210 91 86 81 79 72 741
Carla Mercado United States 14 201 1.0× 35 0.4× 93 1.1× 63 0.8× 168 2.1× 33 871
Francisco J. Morales‐Olivas Spain 15 428 2.0× 93 1.0× 109 1.3× 109 1.3× 184 2.3× 72 1.2k
A Sturani Italy 13 419 2.0× 122 1.3× 39 0.5× 121 1.5× 69 0.9× 58 792
Choy‐Lye Chei Japan 20 206 1.0× 49 0.5× 74 0.9× 98 1.2× 239 3.0× 38 948
Yanan Qiao China 18 178 0.8× 58 0.6× 81 0.9× 68 0.8× 109 1.4× 39 966
L. A. Leiter Canada 9 179 0.9× 35 0.4× 48 0.6× 133 1.6× 118 1.5× 14 561
Ovidio Brignoli Italy 18 647 3.1× 199 2.2× 95 1.1× 112 1.4× 133 1.7× 52 1.4k
James F. Burris United States 16 314 1.5× 54 0.6× 69 0.8× 91 1.1× 47 0.6× 61 710
Renate Zilkens Australia 21 108 0.5× 31 0.3× 65 0.8× 56 0.7× 121 1.5× 46 1.1k
Bruce M. Psaty United States 10 562 2.7× 59 0.6× 93 1.1× 123 1.5× 82 1.0× 12 961

Countries citing papers authored by Thomas L. Lenz

Since Specialization
Citations

This map shows the geographic impact of Thomas L. Lenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas L. Lenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas L. Lenz more than expected).

Fields of papers citing papers by Thomas L. Lenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas L. Lenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas L. Lenz. The network helps show where Thomas L. Lenz may publish in the future.

Co-authorship network of co-authors of Thomas L. Lenz

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas L. Lenz. A scholar is included among the top collaborators of Thomas L. Lenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas L. Lenz. Thomas L. Lenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
White, Nicole D., et al.. (2013). Comparison of cardiovascular risk calculation tools in pharmacy practice. Journal of the American Pharmacists Association. 53(4). 408–413. 5 indexed citations
2.
Lenz, Thomas L., et al.. (2012). Using employee experts to offer an interprofessional diabetes risk reduction program to fellow employees. Journal of Interprofessional Care. 27(2). 197–199. 4 indexed citations
3.
Lenz, Thomas L. & Michael S. Monaghan. (2011). Implementing lifestyle medicine with medication therapy management services to improve patient-centered health care. Journal of the American Pharmacists Association. 51(2). 184–188. 12 indexed citations
4.
Lenz, Thomas L. & Michael S. Monaghan. (2011). Pay-for-performance model of medication therapy management in pharmacy practice. Journal of the American Pharmacists Association. 51(3). 425–431. 10 indexed citations
5.
Lenz, Thomas L., et al.. (2011). Transdermal Patch Drug Delivery Interactions with Exercise. Sports Medicine. 41(3). 177–183. 10 indexed citations
6.
Lenz, Thomas L.. (2011). The effects of high physical activity on pharmacokinetic drug interactions. Expert Opinion on Drug Metabolism & Toxicology. 7(3). 257–266. 25 indexed citations
7.
Lenz, Thomas L., et al.. (2010). A Lifestyle Medicine Clinic in a Community Pharmacy Setting. SHILAP Revista de lepidopterología. 1(1). 9 indexed citations
8.
Foral, Pamela A., Paul D. Turner, Michael S. Monaghan, et al.. (2010). Faculty and Student Expectations and Perceptions of E-mail Communication in a Campus and Distance Doctor of Pharmacy Program. American Journal of Pharmaceutical Education. 74(10). 191–191. 15 indexed citations
9.
Lenz, Thomas L.. (2008). Effects of Food on the Most Commonly Used Medications in School-Age Children. American Journal of Lifestyle Medicine. 3(2). 119–122.
10.
Lenz, Thomas L.. (2007). An Elective Course on Lifestyle Modifications in Pharmacotherapy. American Journal of Pharmaceutical Education. 71(5). 92–92. 2 indexed citations
11.
Lenz, Thomas L., et al.. (2006). Using Performance-based Assessments to Evaluate Parity Between a Campus and Distance Education Pathway. American Journal of Pharmaceutical Education. 70(4). 90–90.
12.
Lenz, Thomas L., et al.. (2006). Using Performance-based Assessments to Evaluate Parity Between a Campus and Distance Education Pathway. American Journal of Pharmaceutical Education. 70(4). 90–90. 26 indexed citations
13.
Lenz, Thomas L., et al.. (2006). An interprofessional medication risk assessment program. Journal of Interprofessional Care. 20(5). 558–560. 2 indexed citations
14.
Faulkner, Michele A., et al.. (2005). Osteoporosis in Long-Term Care Residents with Multiple Sclerosis. The Consultant Pharmacist. 20(2). 128–136. 4 indexed citations
15.
Lenz, Thomas L., et al.. (2005). Lifestyle Modification Counseling of Patients with Dyslipidemias by Pharmacists and Other Health Professionals. Journal of the American Pharmacists Association. 45(6). 709–713. 9 indexed citations
16.
Lenz, Thomas L.. (2005). Therapeutic Lifestyle Changes and Pharmaceutical Care in the Treatment of Dyslipidemias in Adults. Journal of the American Pharmacists Association. 45(4). 492–502. 12 indexed citations
17.
Lenz, Thomas L., Pamela A. Foral, Mark A. Malesker, et al.. (2004). Impact of Nesiritide on Health Care Resource Utilization and Complications in Patients with Decompensated Heart Failure. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(9). 1137–1146. 12 indexed citations
18.
Lenz, Thomas L., et al.. (2004). Potential Interactions between Exercise and Drug Therapy. Sports Medicine. 34(5). 293–306. 55 indexed citations
19.
Mooss, Aryan N., Richard L. Wurdeman, Jeffrey T. Sugimoto, et al.. (2004). Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: The Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. American Heart Journal. 148(4). 641–648. 23 indexed citations
20.
Hilleman, Daniel E., Richard L. Wurdeman, & Thomas L. Lenz. (2001). Therapeutic Change of HMG‐CoA Reductase Inhibitors in Patients with Coronary Artery Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(4). 410–415. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Mercado Breakdown of academic impact, for papers by Francisco J. Morales‐Olivas Breakdown of academic impact, for papers by A Sturani Breakdown of academic impact, for papers by Choy‐Lye Chei Breakdown of academic impact, for papers by Yanan Qiao Breakdown of academic impact, for papers by L. A. Leiter Breakdown of academic impact, for papers by Ovidio Brignoli Breakdown of academic impact, for papers by James F. Burris Breakdown of academic impact, for papers by Renate Zilkens Breakdown of academic impact, for papers by Bruce M. Psaty
Rankless by CCL
2026